Incyte in Canada
E-mail: IncyteCanadaInquiry@Incyte.com.
Web: https://www.incytebiosciences.ca/
Address:
-
Incyte Biosciences Canada Corporation
6500 Trans-Canada Highway, Suite 400 Pointe-Claire, Quebec Canada H9R 0A5
Phone: +1 833-309-2759
Other Incyte's locations around the world
Clinical Trials sponsored by Incyte
-
Incyte Biosciences UKAfsluttetAccelereret fase kronisk myelogen leukæmi | Kronisk fase Kronisk myelogen leukæmi | Philadelphia kromosom-positiv akut lymfoblastisk leukæmi | Blastisk fase kronisk myelogen leukæmiDet Forenede Kongerige, Irland
-
Incyte Biosciences Japan GKRekrutteringDiffust storcellet B-celle lymfom | Non Hodgkins lymfomJapan
-
Incyte Biosciences International SàrlAfsluttetAvancerede maligniteterForenede Stater
-
Incyte Biosciences International SàrlAfsluttetMetastatisk kræft | Avancerede maligniteterForenede Stater
-
Incyte Biosciences International SàrlAfsluttetLivmoderhalskræft | Hepatocellulært karcinom | Spiserørskræft | Livmoderhalskræft | Mesotheliom | Ikke-småcellet lungekræft (NSCLC) | Urothelialt karcinom | Merkel cellekarcinom | Diffust storcellet B-celle lymfom | Triple-negativ brystkræft | Nyrecellekarcinom (RCC) | Småcellet lungekræft (SCLC) | Planocellulært karcinom... og andre forholdForenede Stater
-
Incyte Biosciences International SàrlTrukket tilbageBCR-ABL Positiv Akut Lymfoblastisk LeukæmiTyskland, Frankrig, Tjekkiet
-
Incyte CorporationIkke rekrutterer endnu
-
Incyte CorporationRekrutteringHidradenitis Suppurativa (HS)Forenede Stater, Østrig, Belgien, Canada, Tyskland, Polen, Spanien, Australien, Danmark, Frankrig, Det Forenede Kongerige, Japan, Bulgarien, Holland, Tjekkiet, Grækenland, Italien
-
Incyte CorporationRekrutteringIkke-segmentel vitiligoTyskland, Forenede Stater, Italien, Polen, Canada, Frankrig, Bulgarien, Ungarn, Det Forenede Kongerige
-
Incyte CorporationRekrutteringMyeloproliferative neoplasmerSpanien, Japan, Frankrig, Italien, Tyskland, Australien, Det Forenede Kongerige, Danmark, Canada
About Incyte
Incyte is a global biopharmaceutical company founded on the premise that investment in strong science and the relentless pursuit of R&D excellence can translate into new solutions that can positively affect patients’ lives. Our drug discovery and development efforts were founded in 2002 in Wilmington, Delaware, by a team of research scientists, chemists and biologists working in immunology. Today, we employ approximately 1500 people and have operations in the U.S., Europe and Japan. Our unique expertise in medicinal chemistry and biology have enabled us to create a diversified portfolio of marketed products and clinical candidates, the majority of which were discovered by Incyte scientists. We are advancing a growing pipeline of medicines across two franchises: Oncology and Inflammation & Autoimmunity. The commitment of our talented team of world-class scientists to continued scientific excellence has enabled us to identify new molecules, decipher new pathways and develop first-in-class and best-in-class medicines.